164 related articles for article (PubMed ID: 35814383)
1. Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer.
Chuong MD; Herrera R; Kaiser A; Rubens M; Romaguera T; Alvarez D; Kotecha R; Hall MD; McCulloch J; Ucar A; DeZarraga F; Aparo S; Joseph S; Asbun H; Jimenez R; Narayanan G; Gutierrez AN; Mittauer KE
Front Oncol; 2022; 12():888462. PubMed ID: 35814383
[TBL] [Abstract][Full Text] [Related]
2. Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART).
Bryant JM; Palm RF; Herrera R; Rubens M; Hoffe SE; Kim DW; Kaiser A; Ucar A; Fleming J; De Zarraga F; Hodul P; Aparo S; Asbun H; Malafa M; Jimenez R; Denbo J; Frakes JM; Chuong MD
Cancer Control; 2023; 30():10732748221150228. PubMed ID: 36598464
[TBL] [Abstract][Full Text] [Related]
3. Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer.
Chuong MD; Bryant J; Mittauer KE; Hall M; Kotecha R; Alvarez D; Romaguera T; Rubens M; Adamson S; Godley A; Mishra V; Luciani G; Gutierrez AN
Pract Radiat Oncol; 2021; 11(2):134-147. PubMed ID: 32947042
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study.
Chuong MD; Lee P; Low DA; Kim J; Mittauer KE; Bassetti MF; Glide-Hurst CK; Raldow AC; Yang Y; Portelance L; Padgett KR; Zaki B; Zhang R; Kim H; Henke LE; Price AT; Mancias JD; Williams CL; Ng J; Pennell R; Raphael Pfeffer M; Levin D; Mueller AC; Mooney KE; Kelly P; Shah AP; Boldrini L; Placidi L; Fuss M; Jitendra Parikh P
Radiother Oncol; 2024 Feb; 191():110064. PubMed ID: 38135187
[TBL] [Abstract][Full Text] [Related]
5. Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy.
Chuong MD; Herrera R; Ucar A; Aparo S; De Zarraga F; Asbun H; Jimenez R; Asbun D; Narayanan G; Joseph S; Kotecha R; Hall MD; Mittauer KM; Alvarez D; McCulloch J; Romaguera T; Gutierrez A; Kaiser A
Adv Radiat Oncol; 2023; 8(1):101084. PubMed ID: 36483070
[TBL] [Abstract][Full Text] [Related]
6. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.
Parikh PJ; Lee P; Low DA; Kim J; Mittauer KE; Bassetti MF; Glide-Hurst CK; Raldow AC; Yang Y; Portelance L; Padgett KR; Zaki B; Zhang R; Kim H; Henke LE; Price AT; Mancias JD; Williams CL; Ng J; Pennell R; Pfeffer MR; Levin D; Mueller AC; Mooney KE; Kelly P; Shah AP; Boldrini L; Placidi L; Fuss M; Chuong MD
Int J Radiat Oncol Biol Phys; 2023 Nov; 117(4):799-808. PubMed ID: 37210048
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system.
Tringale KR; Tyagi N; Marsha Reyngold ; Romesser PB; Wu A; O'Reilly EM; Varghese AM; Godoy Scripes P; Khalil DN; Park W; Yu K; Crane CH
Phys Imaging Radiat Oncol; 2022 Oct; 24():88-94. PubMed ID: 36386447
[TBL] [Abstract][Full Text] [Related]
8. Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma.
Webking S; Sandoval ML; Chuong MD; Ucar A; Aparo S; De Zarraga F; Sahin I; Biachi T; Kim DW; Hoffe SE; Frakes JM; Palm RF
Cancer Control; 2023; 30():10732748231219069. PubMed ID: 38038261
[TBL] [Abstract][Full Text] [Related]
9. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy
Kutuk T; Herrera R; Mustafayev TZ; Gungor G; Ugurluer G; Atalar B; Kotecha R; Hall MD; Rubens M; Mittauer KE; Contreras JA; McCulloch J; Kalman NS; Alvarez D; Romaguera T; Gutierrez AN; Garcia J; Kaiser A; Mehta MP; Ozyar E; Chuong MD
Adv Radiat Oncol; 2022; 7(6):100978. PubMed ID: 35647412
[TBL] [Abstract][Full Text] [Related]
10. Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART).
Bryant JM; Palm RF; Liveringhouse C; Boyer E; Hodul P; Malafa M; Denbo J; Kim D; Carballido E; Fleming JB; Hoffe S; Frakes J
Adv Radiat Oncol; 2022; 7(6):101045. PubMed ID: 36420193
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
Sahin B; Atalar B; Kaytan Saglam E; Akgun Z; Abacioglu U; Arifoglu A; Ozyar E; Yaprak G; Ozseker Isik N; Guney Y; Caglar HB; Karaman S; Igdem S; Selek U; Berber T; Oner Dincbas F; Sengoz M; Yucel S; Demiral AN; Akyurek S
Clin Respir J; 2020 Nov; 14(11):1050-1059. PubMed ID: 32749053
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer outcome-local treatment with radiation using MRI-LINAC.
Almog G; Pfeffer RM; Zalmanov S; Grinberg V; Lipsky Y; Chernomordikov E; Levin D; Apter S; Arsenault O; Epstein D; Tamimi Q; Hod K; Limon D; Golan T; Ben-Aharon I; Lawrence YR; Ben-David MA
Front Oncol; 2023; 13():1289919. PubMed ID: 38074644
[TBL] [Abstract][Full Text] [Related]
13. Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer.
Rossi G; Simoni N; Paiella S; Rossi R; Venezia M; Micera R; Malleo G; Salvia R; Giuliani T; Di Gioia A; Auriemma A; Milella M; Guariglia S; Cavedon C; Bassi C; Mazzarotto R
Front Oncol; 2021; 11():662205. PubMed ID: 33959509
[TBL] [Abstract][Full Text] [Related]
14. Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation.
Hassanzadeh C; Rudra S; Bommireddy A; Hawkins WG; Wang-Gillam A; Fields RC; Cai B; Park J; Green O; Roach M; Henke L; Kim H
Adv Radiat Oncol; 2021; 6(1):100506. PubMed ID: 33665480
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study.
Bordeau K; Michalet M; Keskes A; Valdenaire S; Debuire P; Cantaloube M; Cabaillé M; Portales F; Draghici R; Ychou M; Assenat E; Mazard T; Samalin E; Gauthier L; Colombo PE; Carrere S; Souche FR; Aillères N; Fenoglietto P; Azria D; Riou O
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612004
[TBL] [Abstract][Full Text] [Related]
16. Consolidatory ablative stereotactic body radiation therapy after induction chemotherapy for unresectable pancreatic cancer: A single center experience.
Lee HI; Kang HC; Chie EK
Front Oncol; 2022; 12():974454. PubMed ID: 36505838
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis.
Yoon SM; Luterstein E; Chu FI; Cao M; Lamb J; Agazaryan N; Low D; Raldow A; Steinberg ML; Lee P
Cancer Med; 2021 Sep; 10(17):5897-5906. PubMed ID: 34288538
[TBL] [Abstract][Full Text] [Related]
18. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer.
Rudra S; Jiang N; Rosenberg SA; Olsen JR; Roach MC; Wan L; Portelance L; Mellon EA; Bruynzeel A; Lagerwaard F; Bassetti MF; Parikh PJ; Lee PP
Cancer Med; 2019 May; 8(5):2123-2132. PubMed ID: 30932367
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients.
Ryan JF; Rosati LM; Groot VP; Le DT; Zheng L; Laheru DA; Shin EJ; Jackson J; Moore J; Narang AK; Herman JM
Oncotarget; 2018 Mar; 9(23):16427-16436. PubMed ID: 29662656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
